Details of the Drug

General Information of Drug (ID: DMKJ7WA)

• Drug Name: ERC-1671

Indication

Disease Entry	ICD 11	Status	REF
Glioma	2A00.0	Phase 2	[1]
Lymphoma	2A80-2A86	Phase 2	[2]
Recurrent glioblastoma	2A00.00	Phase 2	[3]

• Cross-matching ID: TTD ID: D0W1AR
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] ClinicalTrials.gov (NCT01903330) ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme. U.S. National Institutes of Health.
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)